No description
-
2019 (v1)PublicationUploaded on: April 14, 2023
-
2020 (v1)Publication
Immune-checkpoint inhibitors (ICIs) represent a successful paradigm in the treatment of cancer. ICIs elicit an immune response directed against cancer cells, by targeting the so-called immune checkpoints, key regulators of the immune system that when stimulated can dampen the immune response to an immunologic stimulus. Such response, however,...
Uploaded on: April 14, 2023 -
2024 (v1)Publication
COVID-19 has been a challenging outbreak to face, with millions of deaths among the globe. Acute respiratory failure due to interstitial pneumonia was the leading cause of death other than prothrombotic activation and complications. Lung ultrasound (LUS) and point-of-care ultrasound (POCUS) are widely used not only to triage, to identify, and...
Uploaded on: July 3, 2024 -
2015 (v1)Publication
Background: Peripheral T-cell lymphomas (PTCL) represent a heterogeneous group of hematologic malignancies frequently presenting at advanced stage of diagnosis.Methods: We report a case of PTCL with an uncommon and aggressive onset with disseminated intravascular coagulation (DIC).Results: Laboratory findings revealed an aberrant expression of...
Uploaded on: April 14, 2023 -
2022 (v1)Publication
Besides its terrible claim in terms of human lives, SARSCoV-2 pandemic hit hard also on the hospital management with most healthcare facilities being overwhelmed by hundreds of patients with SARS-CoV-2–related symptoms
Uploaded on: March 27, 2023 -
2021 (v1)Publication
Background: Viral RNA amplification by real-time RT-PCR still represents the gold standard for the detection of SARS-CoV-2, but the development of rapid, reliable and easy-to-perform diagnostic methods is crucial for public health, because of the need of shortening the time of result-reporting with a cost-efficient approach. Objectives: The aim...
Uploaded on: February 4, 2024 -
2019 (v1)Publication
The great therapeutical success achieved by oncology is counterbalanced by growing evidences of cardiovascular (CV) toxicity due to many antineoplastic treatments. Cardiac adverse events may cause premature discontinuation of effective oncologic treatments or occur as late events undermining the oncologic success. Arterial hypertension is both...
Uploaded on: April 14, 2023 -
2019 (v1)Publication
Background: Patients developing cancer treatment-related left ventricular dysfunction (CTrLVD) require a prompt therapy. Hypotension, dizziness, and fatigue often limit the use of angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), and ?-blockers (BB) in cancer patients who may already be afflicted by these...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
During epidemic outbreaks, epilepsy course can be modified by different physical and psychological stressors and, most importantly, by irregular therapy intake. The effect of COVID-19 and quarantine isolation on the course of epilepsy and on incidence of new-onset seizures is still unclear. With the aim of managing epilepsy in quarantined...
Uploaded on: April 14, 2023 -
2020 (v1)Publication
Metabolic syndrome (MetS) is a well established risk factor for cardiovascular (CV) diseases. In addition, several studies indicate that MetS correlates with the increased risk of cancer in adults. The mechanisms linking MetS and cancer are not fully understood. Several risk factors involved in MetS are also cancer risk factors, such as the...
Uploaded on: April 14, 2023 -
2023 (v1)Publication
Clinical trials demonstrated that SARS-CoV-2 vaccines reduce COVID-19-related mortality and morbidity. We describe the effect of vaccination on COVID-19-patients admitted at our hospital. Retrospective, single-center study conducted in Genoa, Italy, including patients ≥18years hospitalized for COVID-19 from May to December 2021. Demographical...
Uploaded on: February 4, 2024